BioMed Central, Genome Biology, 8(15), 2014
DOI: 10.1186/s13059-014-0438-7
Full text: Download
Interpretation of the clinical significance of genomic alterations remains the most severe bottleneck preventing the realization of personalized medicine in cancer. We propose a knowledge commons to facilitate collaborative contributions and open discussion of clinical decision-making based on genomic events in cancer.